Jeffrey D. Kahl
Chief Tech/Sci/R&D Officer at Azaya Therapeutics, Inc.
Jeffrey D. Kahl active positions
| Companies | Position | Start | End |
|---|---|---|---|
Azaya Therapeutics, Inc.
 Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Jeffrey D. Kahl
Former positions of Jeffrey D. Kahl
| Companies | Position | Start | End |
|---|---|---|---|
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Chief Tech/Sci/R&D Officer | - | - |
Training of Jeffrey D. Kahl
| Texas Tech University | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Health Technology |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |
- Stock Market
- Insiders
- Jeffrey D. Kahl
- Experience
